Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator†

M Frederickson, O Callaghan, G Chessari…

Index: Journal of Medicinal Chemistry, , vol. 51, # 2 p. 183 - 186

Full Text: HTML

Citation Number: 42

Abstract

... Journal of Medicinal Chemistry. ... Pharm. Des. 2004 10 39 49 [CrossRef], [PubMed], [CAS] 1. The urokinase plasminogen activator system: Role in malignancy. Duffy, Michael J. Current Pharmaceutical Design (2004), 10 (1), 39-49CODEN: CPDEFP ; ISSN:1381-6128. ...